RxDoctor Payments Data

Natasha Baczewski, DPM

Foot & Ankle Surgery · Portsmouth, NHNPI 1427287663

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Stryker at 35.9% of the total. Reporting peaked in 2021 at $179 and has fallen 92.4% since, to $14 in 2025. That places this record below the midpoint for foot & ankle surgery clinicians in NH, where the typical reported total is $513.

$513in general payments, 2019–2025

Across 20 payments — averaging $25.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$184
  • Orthofix Medical, Inc.$54
  • Dynasplint Systems Inc.$45
  • Paragon 28, Inc.$41
  • Bioventus LLC$35
  • Smith+Nephew$28
  • plus $127 from 7 others

What the payments were for

  • Food & beverage$513100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$513 in reported general payments places this provider in the 50th percentile of 23 foot & ankle surgery providers in New Hampshire.

See all foot & ankle surgery providers in New Hampshire

Medicare billing

Part B allowed, 2024
$92,411
Medicare patients
324
Services billed
1,161

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cephalexin15$466
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen14$106

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Portsmouth

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →